US Patent Issued to TYK MEDICINES on May 19 for "Compound used as RET kinase inhibitor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,358, issued on May 19, was assigned to TYK MEDICINES INC. (Huzhou, China).

"Compound used as RET kinase inhibitor and application thereof" was invented by Jun Li (Huzhou, China), Maolin Zheng (Huzhou, China), Chengshan Niu (Huzhou, China), Apeng Liang (Huzhou, China) and Yusheng Wu (Huzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I'), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the present invention may be...